Full name
ETG WARSZAWA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.19.Z - Scientific research and development activities
72.11.Z - Scientific research and development activities
72.20.Z - Scientific research and development in social sciences and humanities
86.21.Z - General medical practice
86.22.Z - Specialist medical practice
86.23.Z - Dental practice
86.90.A - Healthcare
86.90.D - Healthcare
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0 | 2,2 | 1,1 | -51,5 |
EBITDA | -0 | 2,3 | 1,3 | -42 |
Short time liabilities | 0 | 1 | 1,2 | 18 |
Income tax | 0 | |||
Equity capital | -0 | 2,1 | 0,7 | -67,7 |
Operating profit (EBIT) | -0 | 2,2 | 1,2 | -45,4 |
Assets | 0 | 5,3 | 2,4 | -54,5 |
Net profit (loss) | -0 | 2,1 | 0,9 | -55,8 |
Cash | 0 | 0,2 | 0,3 | 80,8 |
Net income from sale | 0 | 6 | 9,7 | 60,7 |
Liabilities and provisions for liabilities | 0 | 1 | 1,7 | 66,1 |
Working assets | 0 | 5,3 | 2,3 | -57,1 |
Depreciation | 0 | 0 | 0,1 | 330,4 |
Basic operational activity income | 0 | |||
% | % | % | p.p. | |
Profitability of capital | 115 | 101,6 | 138,9 | 37,3 |
Equity capital to total assets | -411,8 | 39,9 | 28,3 | -11,6 |
Gross profit margin | -1280,4 | 37,3 | 11,2 | -26,1 |
EBITDA Margin | -1280,4 | 37,6 | 13,6 | -24 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 5052 | 63 | 46 | -17 |
Current financial liquidity indicator | 0.1953851878643036 | 5.088315486907959 | 1.3136894702911377 | -3,8 |
Net dept to EBITDA | 0.1103515475988388 | -0.07217792421579361 | -0.22510920464992523 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane